Xianghui Du

496 total citations
19 papers, 228 citations indexed

About

Xianghui Du is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology. According to data from OpenAlex, Xianghui Du has authored 19 papers receiving a total of 228 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Xianghui Du's work include Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Reproductive System and Pregnancy (4 papers). Xianghui Du is often cited by papers focused on Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Reproductive System and Pregnancy (4 papers). Xianghui Du collaborates with scholars based in China. Xianghui Du's co-authors include Binqing Fu, Haiming Wei, Liming Sheng, Yingchao Dou, Xiaohu Zheng, Guoqin Qiu, Yonggang Zhou, Rui Sun, Yang Yang and Li Zhou and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and Clinical Cancer Research.

In The Last Decade

Xianghui Du

19 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianghui Du China 8 131 72 68 57 40 19 228
Maria Kfoury France 7 229 1.7× 132 1.8× 59 0.9× 19 0.3× 46 1.1× 22 295
Maximilian Fleischmann Germany 9 96 0.7× 31 0.4× 32 0.5× 26 0.5× 109 2.7× 31 271
Christophe Attencourt France 8 79 0.6× 92 1.3× 21 0.3× 32 0.6× 38 0.9× 26 218
Xianghua Zeng China 9 82 0.6× 36 0.5× 37 0.5× 73 1.3× 54 1.4× 17 223
Zhongqiu Lin China 10 89 0.7× 47 0.7× 21 0.3× 19 0.3× 143 3.6× 19 254
Sandrine Richard France 8 100 0.8× 18 0.3× 46 0.7× 16 0.3× 39 1.0× 22 188
Ami Patel United States 9 66 0.5× 27 0.4× 17 0.3× 18 0.3× 82 2.0× 24 261
Gonzalo Tapia Rico Australia 10 173 1.3× 37 0.5× 41 0.6× 65 1.1× 32 0.8× 25 261
Cecilia Egoavil Spain 12 164 1.3× 13 0.2× 53 0.8× 19 0.3× 139 3.5× 20 380

Countries citing papers authored by Xianghui Du

Since Specialization
Citations

This map shows the geographic impact of Xianghui Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianghui Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianghui Du more than expected).

Fields of papers citing papers by Xianghui Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianghui Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianghui Du. The network helps show where Xianghui Du may publish in the future.

Co-authorship network of co-authors of Xianghui Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xianghui Du. A scholar is included among the top collaborators of Xianghui Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianghui Du. Xianghui Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Yihang, Jinghe Zhang, Xianghui Du, et al.. (2025). Maternal natural killer cells drive neuroimmune disorders in offspring through aberrant secretion of extracellular granzyme B. Immunity. 58(6). 1502–1518.e8. 4 indexed citations
2.
Chen, Siao, Jinghe Zhang, Jianmin Chen, et al.. (2024). Compromised C3b-VSIG4 axis between decidual NK cells and macrophages contributes to recurrent spontaneous abortion. Journal of Translational Medicine. 22(1). 1017–1017. 3 indexed citations
3.
Dou, Yingchao, Yiqing Shen, Xianghui Du, et al.. (2024). Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation. Immunity. 57(10). 2344–2361.e7. 34 indexed citations
4.
Zhang, Jinghe, Weidong Zhao, Yonggang Zhou, et al.. (2024). Pyroptotic T cell-derived active IL-16 has a driving function in ovarian endometriosis development. Cell Reports Medicine. 5(3). 101476–101476. 9 indexed citations
5.
Liu, Jianjiang, Dongping Wu, Mengyuan Chen, et al.. (2023). A nomogram to predict the cumulative risk for brain metastases in patients with limited-stage small cell lung cancer without prophylactic cranial irradiation. Strahlentherapie und Onkologie. 199(8). 727–738. 4 indexed citations
6.
Bai, Xue, et al.. (2023). Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer. Future Oncology. 19(32). 2157–2169. 3 indexed citations
7.
Du, Xianghui, Huaiping Zhu, Defeng Jiao, et al.. (2022). Human-Induced CD49a+ NK Cells Promote Fetal Growth. Frontiers in Immunology. 13. 821542–821542. 24 indexed citations
8.
Yang, Yang, Mengyuan Chen, Yongling Ji, et al.. (2022). Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer. Frontiers in Oncology. 12. 778898–778898. 6 indexed citations
9.
Liu, Jianjiang, Dongping Wu, Mengyuan Chen, et al.. (2022). Serum lactate dehydrogenase predicts brain metastasis and survival in limited-stage small cell lung cancer patients treated with thoracic radiotherapy and prophylactic cranial irradiation. Strahlentherapie und Onkologie. 198(12). 1094–1104. 7 indexed citations
10.
Chen, Ying, et al.. (2022). Thyroid Dysfunction as a Predictive Indicator in Camrelizumab of Advanced Esophageal Squamous Cell Carcinoma. Journal of Immunology Research. 2022. 1–8. 3 indexed citations
11.
12.
Zheng, Xiaohu, Yingchao Dou, Xianghui Du, et al.. (2021). Rapamycin Pretreatment Rescues the Bone Marrow AML Cell Elimination Capacity of CAR-T Cells. Clinical Cancer Research. 27(21). 6026–6038. 43 indexed citations
13.
Jiao, Defeng, Xiaohu Zheng, Xianghui Du, et al.. (2021). Immunogenic senescence sensitizes lung cancer to LUNX-targeting therapy. Cancer Immunology Immunotherapy. 71(6). 1403–1417. 5 indexed citations
14.
Yang, Yang, et al.. (2019). Role of Perioperative Chemotherapy in Lymph Node-negative Esophageal Cancer After Resection. American Journal of Clinical Oncology. 42(12). 924–931. 3 indexed citations
15.
Sheng, Liming, et al.. (2019). Risk factors of grade ≥ 2 radiation pneumonitis after gemcitabine induction chemotherapy for patients with non-small cell lung cancer. Radiation Oncology. 14(1). 229–229. 13 indexed citations
16.
Sheng, Liming & Xianghui Du. (2018). Efficacy and safety of liposome-paclitaxel and carboplatin based concurrent chemoradiotherapy for locally advanced lung squamous cell carcinoma.. Journal of Clinical Oncology. 36(15_suppl). e20516–e20516. 2 indexed citations
17.
Yang, Yang, Danhong Zhang, Xia Zhou, et al.. (2017). Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis. Journal of Cancer. 9(2). 433–439. 42 indexed citations
18.
Che, Ruochen, et al.. (2015). Use of off-label nephrology-related drugs in hospitalized pediatric patients: a retrospective study. World Journal of Pediatrics. 12(2). 236–242. 2 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Kfoury Breakdown of academic impact, for papers by Maximilian Fleischmann Breakdown of academic impact, for papers by Christophe Attencourt Breakdown of academic impact, for papers by Xianghua Zeng Breakdown of academic impact, for papers by Zhongqiu Lin Breakdown of academic impact, for papers by Sandrine Richard Breakdown of academic impact, for papers by Ami Patel Breakdown of academic impact, for papers by Gonzalo Tapia Rico Breakdown of academic impact, for papers by Cecilia Egoavil
Rankless by CCL
2026